مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

451
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

160
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

SUPPRESSION OF TELOMERASE ACTIVITY BY PYRIMETHAMINE: IMPLICATION TO CANCER

Pages

  223-228

Keywords

MATRIX METALLOPROTEINASES (MMP) 

Abstract

 Background: Although PYRIMETHAMINE (Tindurin™) appears to be effective in the prevention and treatment of some infectious diseases, very little information exists on its unpredictable properties. We design this study to evaluate its anti-tumoral effect on a model of cell line.Methods: The cytotoxic influence of PYRIMETHAMINE on prostate cell line was investigated using an in vitro colometric assay. The potential modulatory effects on metastasis, apoptosis, and immortality characteristics of cells were assessed with gelatin zymography, terminal deoxyribonucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay and telomeric repeat amplification protocol, respectively.Results: Cytotoxicity analysis of PYRIMETHAMINE revealed a dosedependent fashion. An apoptotic influence of PYRIMETHAMINE was also confirmed by data obtained from TUNEL assay. Dose-dependent inhibitory effect on matrix metalloproteinases (MMP) was seen in PYRIMETHAMINE. A potent inhibitory effect of PYRIMETHAMINE was also established by data achieved from TRAPeze TELOMERASE detection kit.Conclusions: Collectively, as induction of apoptosis together with MMP and TELOMERASE inhibition could be indicative of CANCER treatment, PYRIMETHAMINE might be considered as a chemopreventative agent in CANCER.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    KHORAMIZADEH, MOHAMMAD REZA, SAADAT, F., VAEZZADEH, F., SAFAVIFAR, F., BASHIRI, H., JAHAN SHIRI, Z., MOUMENI, M.,. (2007). SUPPRESSION OF TELOMERASE ACTIVITY BY PYRIMETHAMINE: IMPLICATION TO CANCER. IRANIAN BIOMEDICAL JOURNAL, 11(4), 223-228. SID. https://sid.ir/paper/277162/en

    Vancouver: Copy

    KHORAMIZADEH MOHAMMAD REZA, SAADAT F., VAEZZADEH F., SAFAVIFAR F., BASHIRI H., JAHAN SHIRI Z., MOUMENI M.. SUPPRESSION OF TELOMERASE ACTIVITY BY PYRIMETHAMINE: IMPLICATION TO CANCER. IRANIAN BIOMEDICAL JOURNAL[Internet]. 2007;11(4):223-228. Available from: https://sid.ir/paper/277162/en

    IEEE: Copy

    MOHAMMAD REZA KHORAMIZADEH, F. SAADAT, F. VAEZZADEH, F. SAFAVIFAR, H. BASHIRI, Z. JAHAN SHIRI, M. MOUMENI, an, “SUPPRESSION OF TELOMERASE ACTIVITY BY PYRIMETHAMINE: IMPLICATION TO CANCER,” IRANIAN BIOMEDICAL JOURNAL, vol. 11, no. 4, pp. 223–228, 2007, [Online]. Available: https://sid.ir/paper/277162/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button